Literature DB >> 34981487

The Effect of Green Coffee Bean Extract on Cardiovascular Risk Factors: A Systematic Review and Meta-analysis.

Makan Pourmasoumi1, Amir Hadi2, Wolfgang Marx3, Ameneh Najafgholizadeh4, Sukhdeep Kaur5, Amirhossein Sahebkar6,7,8.   

Abstract

BACKGROUND AND AIM: Cardiovascular disease remains the primary cause of noncommunicable disease- related death. The present systematic review and meta-analysis was performed to assess the possible benefit of the green coffee bean extract on cardio-metabolic markers.
METHODS: PubMed, Scopus, Web of Science, and Cochrane Library were systematically searched to identify clinical trials that examined the effect of green coffee bean extract on cardio-metabolic risk factors including serum lipid profiles, glycemic status-related markers, blood pressure, and anthropometric indices. Since the included RCTs were carried out in different settings, random effect models were used to conduct all meta-analyses.
RESULTS: Fifteen studies (19 arms) consisting of 637 participants were included. The results indicated that green coffee bean extract significantly reduced levels of total cholesterol (-5.93 mg/dl; 95% CI: -9.21, -2.65; I2: 0%), fasting plasma glucose (-2.21 mg/dl; 95% CI: -3.94, -0.48; I2: 32%), systolic blood pressure (-3.08 mmHg; 95% CI: -4.41, -1.75; I2: 26%), diastolic blood pressure (-2.27 mmHg; 95% CI: -3.82, -0.72; I2: 61%), body weight (-1.24 kg; 95% CI: -1.82, -0.66; I2: 15%), and BMI (-0.55 kg/m2; 95% CI: -0.88, -0.22; I2: 73%). Although the pooled effect size of LDL-C, fasting insulin, and waist circumstance were significant, the results were significantly influenced by individual studies. No significant effect was detected for triglycerides, HDL-C, HbA1C, and HOMA-IR. However, the nonsignificant pooled effect size for triglyceride levels was influenced by one individual study.
CONCLUSION: The present study suggests that green coffee been extract consumption can improve total cholesterol, triglycerides, body weight, blood pressure, and fasting plasma glucose.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  CVD; Cardiovascular disease; Chlorogenic acid; Green coffee

Mesh:

Substances:

Year:  2021        PMID: 34981487     DOI: 10.1007/978-3-030-73234-9_21

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  33 in total

1.  Clinical evidence on the effects of saffron (Crocus sativus L.) on cardiovascular risk factors: A systematic review meta-analysis.

Authors:  Makan Pourmasoumi; Amir Hadi; Ameneh Najafgholizadeh; Marzieh Kafeshani; Amirhossein Sahebkar
Journal:  Pharmacol Res       Date:  2018-11-28       Impact factor: 7.658

Review 2.  Psychosocial factors and cardiovascular diseases.

Authors:  Susan A Everson-Rose; Tené T Lewis
Journal:  Annu Rev Public Health       Date:  2005       Impact factor: 21.981

3.  Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle.

Authors:  Daniel Forman; Bernard E Bulwer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-02

Review 4.  Tea, flavonoids, and cardiovascular health: endothelial protection.

Authors:  Davide Grassi; Giovambattista Desideri; Paolo Di Giosia; Martina De Feo; Emanuela Fellini; Paola Cheli; Livia Ferri; Claudio Ferri
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

Review 5.  The Role of Nutraceuticals in Statin Intolerant Patients.

Authors:  Maciej Banach; Angelo Maria Patti; Rosaria Vincenza Giglio; Arrigo F G Cicero; Atanas G Atanasov; Gani Bajraktari; Eric Bruckert; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Stephan von Haehling; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; G B John Mancini; Dimitri P Mikhailidis; Olena Mitchenko; Patrick M Moriarty; Paul Muntner; Dragana Nikolic; Demosthenes B Panagiotakos; Gyorgy Paragh; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Giuseppe M C Rosano; Robert S Rosenson; Jacek Rysz; Amirhossein Sahebkar; Maria-Corina Serban; Dragos Vinereanu; Michal Vrablík; Gerald F Watts; Nathan D Wong; Manfredi Rizzo
Journal:  J Am Coll Cardiol       Date:  2018-07-03       Impact factor: 24.094

Review 6.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

Review 7.  The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Matteo Pirro; Massimo Raffaele Mannarino; Vanessa Bianconi; Luis E Simental-Mendía; Francesco Bagaglia; Elmo Mannarino; Amirhossein Sahebkar
Journal:  Pharmacol Res       Date:  2016-05-06       Impact factor: 7.658

8.  Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring.

Authors:  Asier Sáez-Cirión; Shlomo Nir; Maier Lorizate; Aitziber Agirre; Antonio Cruz; Jesús Pérez-Gil; José L Nieva
Journal:  J Biol Chem       Date:  2002-04-02       Impact factor: 5.157

Review 9.  The pathophysiology of cigarette smoking and cardiovascular disease: an update.

Authors:  John A Ambrose; Rajat S Barua
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

Review 10.  Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer.

Authors:  Sara Arranz; Gemma Chiva-Blanch; Palmira Valderas-Martínez; Alex Medina-Remón; Rosa M Lamuela-Raventós; Ramón Estruch
Journal:  Nutrients       Date:  2012-07-10       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.